Using Blinatumomab in Acute Lymphoblastic Leukemia
0 Ansichten
• 06/15/23
0
0
Einbetten
administrator
Abonnenten
The discussants, Bijal D. Shah, MD, and Raoul Tibes, MD, PhD, elaborate on the administration and safety of bi-specific T-cell engager, blinatumomab, in the treatment of acute lymphoblastic leukemia.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare